The IPO comes with a price band of ₹230-243 and will close on December 23. The IPO is entirely an offer-for-sale of 73.82 lakh equity shares by promoters Mahendra Patel, Nayana Patel ...

Students with high-functioning autism (HFA) often excel academically but face hidden challenges in social interaction, sensory processing, and emotional regulation. These challenges can be ...

Less than three months ago, the Rice County HRA and its partners received applause from federal officials as they broke ground on a first-of-its-kind development in northeastern Faribault that ...

Scope Commercial Real Estate Services arranged the auction of a 230-unit garden-style apartment community in Harrisburg, which ultimately went for $21.5M. The nearly 17-acre Taylor Park ...

But don't let it deter you from investing in this future blue chip stock that has already skyrocketed in value by 230% since its all-time low in 2022. What makes Nu one of the best businesses I've ...

Only yesterday, GlaxoSmithKline had warned investors that it expected a generic Advair to hit the US market this year, and forecast the drug’s annual revenues of £1.6 billion would be cut in half.

GlaxoSmithKline has confirmed it will face a challenging 2019 as generics of its big-selling Advair drug finally reach the US, as it continues the transformation of its business. The FDA approved ...